Transparency & Standards

    Our Process & Standards

    Patients travelling for regenerative medicine are making a significant decision. This page exists to explain, step by step, how we evaluate patients, select candidates, perform procedures, and monitor outcomes — so you know exactly what to expect before you commit to anything.

    Regenerative medicine — stem cells, PRP, exosomes — sits in a space where the science is real and the marketing often isn't. Clinics make bold claims about outcomes, obscure where cells come from, and skip the candid conversation about whether the treatment is actually appropriate for a given patient.

    We find that approach counterproductive. Patients who arrive with accurate expectations — about what the treatment can do, what the process involves, and what a realistic timeline looks like — have better experiences and better outcomes. The transparency on this page is not a sales tactic. It's how we actually operate.

    The clinical process, step by step

    Step 1

    Medical evaluation

    Every patient journey starts with a formal medical evaluation — not a sales call. A physician reviews your reason for consultation, current health status, medications, and relevant history. This isn't a formality; it's the basis on which every clinical decision is made.

    Step 2

    Review of history and imaging

    Where relevant, we review existing imaging (MRI, X-ray, ultrasound) and laboratory studies. For musculoskeletal conditions, this tells us the extent of degeneration and which structures are involved. For systemic protocols, blood work guides the approach. We may request additional studies if what you have is insufficient for a reliable assessment.

    Step 3

    Candidacy decision

    Not every patient who enquires is accepted for treatment — and we're straightforward about that. If the evidence doesn't support a meaningful benefit, if the condition is better addressed surgically, or if the timing isn't right, we'll say so. Accepting a patient who isn't a good candidate doesn't serve them or the credibility of the treatment.

    Step 4

    Treatment planning

    For accepted patients, we design a protocol specific to the condition, patient profile, and treatment goals. This includes cell type and source, delivery method, any adjunct therapies (PRP, exosomes, IV nutrition), timing, and what outcomes we are reasonably targeting. You'll know exactly what the plan is before it starts.

    Step 5

    How procedures are performed

    Intraarticular injections are performed under ultrasound guidance so cells are delivered precisely to the target structure. Intravenous protocols are administered under medical supervision in the clinic. We do not perform unsupervised outpatient infusions. Image guidance is standard, not optional — it's the difference between targeted delivery and guesswork.

    Step 6

    Cell source and processing transparency

    Stem cells used at YouMedicine are sourced from accredited tissue banks operating under Colombian INVIMA regulation. We use either autologous (the patient's own) or allogeneic (donor-derived, rigorously screened) mesenchymal stem cells depending on the protocol. We can explain the source, processing, and cell counts for every treatment we recommend. If a provider can't tell you where the cells come from, that is a serious concern.

    Step 7

    Follow-up and monitoring

    Treatment doesn't end when you leave Medellín. We schedule structured follow-up consultations remotely at defined intervals — typically at 4–6 weeks and 12 weeks post-treatment. We track reported outcomes, ask structured questions about function and pain, and are available for questions in between. Outcomes data is collected and informs how we evolve our protocols.

    What makes our approach different

    The single biggest difference is that we say no when the answer is no. We turn away patients who aren't good candidates. That might sound like a modest standard, but it's not universal in this field.

    Beyond that, our procedures are physician-led at every stage. Not nurse-administered after a brief physician overview. Not a protocol run by support staff with a doctor co-signing. A qualified physician is involved in the evaluation, the candidacy decision, the treatment planning, and the procedure itself.

    Image-guided delivery as standard, not optional
    Candidacy refused when not clinically appropriate
    Transparent cell sourcing from INVIMA-regulated banks
    Named physicians who can be looked up and verified
    Structured remote follow-up after every protocol
    Honest communication about realistic outcomes

    Request a medical evaluation

    The first step is a conversation — not a commitment. Tell us about your condition and we'll tell you honestly whether we can help.